With assistance from USP's Promoting the Quality of Medicines (PQM) program, Guatemala’s official medicines control laboratory has retained their ISO 17025 accreditation, a major milestone in its quest to combat the proliferation of poor quality medicines within its borders.
Patrick Lukulay, USP’s VP of GHIP–Africa, discusses plans to leverage his new post in Accra, Ghana to advance pharmaceutical quality in Africa. Countering fallacies in drug quality through advocacy and working to help build an enabling environment that can sustain systems for effective regulation of medical products, he says, are needed for this to happen.
Almost half of the world’s population is at risk of malaria. Malaria Day in the Americas celebrates progress made to prevent, detect, treat and defeat malaria in this region. Learn how Promoting the Quality of Medicines (PQM) is helping by increasing the availability of quality-assured antimalarials.
USP-China is working collaboratively with China’s local governments and other key stakeholders to advance the quality of medicines and food in China and globally.
Everything I have learned and worked toward for pretty much my entire scientific career culminates in the Chief Science Officer role at USP.
USP staff had the opportunity to hear an animated and truly captivating presentation by Dr. Ian Crozier, an infectious disease physician who was infected with Ebola while treating patients during the Ebola outbreak in West Africa last year.
This World TB Day, Promoting the Quality of Medicines (PQM) program celebrates its achievement and commitment to taking an active role in reaching the millions of people with TB who are “missed” by health systems each year and do not get the care they need.
Poor quality medicines are the source of an alarming, but often overlooked global health crisis. A report from the International Policy Network estimates that 700,000 people die every year from fake anti-malarial and tuberculosis drugs alone.